Faes Farma, flagship product Bilastine
20-Sep-21
Undisclosed

Target:
Faes Farma, flagship product Bilastine

Acquiror:
Hikma Specialty USA INC
Advised Faes Farma in the signing of a long-term license agreement for its flagship product Bilastine with Hikma Specialty USA INC, a subsidiary of Hikma Pharmaceuticals PLC, for the United States of America